Next Article in Journal
Demyristoylation of the Cytoplasmic Redox Protein Trx-h2 Is Critical for Inducing a Rapid Cold Stress Response in Plants
Previous Article in Journal
Targeted Ablation of Primary Cilia in Differentiated Dopaminergic Neurons Reduces Striatal Dopamine and Responsiveness to Metabolic Stress
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

EPR Study of KO2 as a Source of Superoxide and BMPO-OH/OOH Radical That Cleaves Plasmid DNA and Detects Radical Interaction with H2S and Se-Derivatives

1
Biomedical Research Center, Department of Molecular Physiology, Institute of Clinical and Translational Research, Slovak Academy of Sciences, Dúbravská Cesta 9, 84505 Bratislava, Slovakia
2
Institute of Physical Chemistry and Chemical Physics, Faculty of Chemical and Food Technology, Slovak University of Technology in Bratislava, Radlinského 9, 81237 Bratislava, Slovakia
3
Biomedical Research Center, Department of Genetics, Cancer Research Institute, Slovak Academy of Sciences, Dúbravská Cesta 9, 84505 Bratislava, Slovakia
4
Division of Bioorganic Chemistry, School of Pharmacy, University of Saarland, D-66123 Saarbruecken, Germany
*
Author to whom correspondence should be addressed.
Antioxidants 2021, 10(8), 1286; https://doi.org/10.3390/antiox10081286
Submission received: 25 June 2021 / Revised: 10 August 2021 / Accepted: 11 August 2021 / Published: 13 August 2021
(This article belongs to the Section ROS, RNS and RSS)

Abstract

:
Superoxide radical anion (O2•−) and its derivatives regulate numerous physiological and pathological processes, which are extensively studied. The aim of our work was to utilize KO2 as a source of O2•− and the electron paramagnetic resonance (EPR) spin trapping 5-tert-butoxycarbonyl-5-methyl-1-pyrroline N-oxide (BMPO) technique for the preparation of BMPO-OOH and/or BMPO-OH radicals in water solution without DMSO. The method distinguishes the interactions of various compounds with BMPO-OOH and/or BMPO-OH radicals over time. Here, we show that the addition of a buffered BMPO-HCl mixture to powdered KO2 formed relatively stable BMPO-OOH and BMPO-OH radicals and H2O2, where the BMPO-OOH/OH ratio depended on the pH. At a final pH of ~6.5–8.0, the concentration of BMPO-OOH radicals was ≥20 times higher than that of BMPO-OH, whereas at pH 9.0–10.0, the BMPO-OH radicals prevailed. The BMPO-OOH/OH radicals effectively cleaved the plasmid DNA. H2S decreased the concentration of BMPO-OOH/OH radicals, whereas the selenium derivatives 1-methyl-4-(3-(phenylselanyl) propyl) piperazine and 1-methyl-4-(4-(phenylselanyl) butyl) piperazine increased the proportion of BMPO-OH over the BMPO-OOH radicals. In conclusion, the presented approach of using KO2 as a source of O2•−/H2O2 and EPR spin trap BMPO for the preparation of BMPO-OOH/OH radicals in a physiological solution could be useful to study the biological effects of radicals and their interactions with compounds.

Graphical Abstract

1. Introduction

Superoxide anion radical (O2•−) is essential for the life of aerobic organisms, regulating numerous physiological and pathophysiological processes. When an overproduction of O2•− occurs and/or the antioxidant defense is deficient, oxidative stress may develop, leading to oxidative damage in many biological systems [1,2]. Therefore, the production, biological interactions, and control of the O2•− concentration have all been intensively studied both in vivo and in vitro.
For experiments involving radical O2•− reactions, O2•− can be generated using various methods [3], e.g., enzymatically by xanthine/xanthine oxidase [4,5], which is a system too complex for some types of O2•− radical models. It can also be generated by ionizing radiation or by dissolving superoxide salts in aprotic solvents, e.g., KO2 in anhydrous DMSO; however, DMSO may not be desirable in some biological experiments [3,6]. On the other hand, KO2 dissolved in an aqueous solution is a simple source of O2, but its lifetime is in the range of milliseconds [7]. For these reasons, it would be practical and appropriate to have an easily accessible O2 source that could be used in physiological solutions. Therefore, the aim of our work was to examine KO2 as a suitable source of O2, which can be used to react with cyclic nitrone 5-tert-butoxycarbonyl-5-methyl-1-pyrroline-N-oxide (BMPO), generating superoxide (BMPO-OOH) or hydroxyl (BMPO-OH) radical adducts for further studies in aqueous systems.
The electron paramagnetic resonance (EPR) spin trapping technique, using BMPO, is useful to study short-lived O2•− and hydroxyl (HO) radicals [4,5,8,9,10,11,12,13,14,15]. By trapping O2•−, BMPO produces relatively stable BMPO-OOH spin adducts, which can be further studied as a potential model for organic hydroperoxides. A saturated KO2 solution in DMSO has been used as a source of O2•− to form BMPO-OOH. The presence of DMSO is convenient in studies with water-insoluble compounds, but it could be a limitation for biological studies.
Exogenously added and endogenously produced hydrogen sulfide (H2S) influences many physiological and pathologic processes, including oxidative stress, by reacting with reactive oxygen species [16,17]. Organoselenium compounds have been known to serve as multifunctional agents. Such compounds have been shown to provide an excellent anti-cancer activity by serving as pro-oxidants that ultimately alter the redox homeostasis of cancer cells, leading to apoptosis. Many biological activities have been associated with organoselenium compounds, ranging from simple antioxidants and antimicrobials, to rather complicated immuno-modulatory, anti-inflammatory, and anti-nociceptive effects [18]. As organoselenium compounds have also been known for their interaction with radicals, the compounds RSe-1 and RSe-2 were employed in this study.
Therefore, in the present work, a new procedure for the preparation of relative stable BMPO-OOH/OH adducts from KO2 as a source of O2•− without the use of DMSO as a solvent is described. The BMPO-OOH radical was mostly observed at pH ~6.5–8.0. BMPO-OOH/OH cleaved plasmid DNA and BMPO-OOH/BMPO-OH total radical concentrations and their proportion were influenced by H2S- and selenium-containing organic compounds.

2. Materials and Methods

2.1. Chemicals, EPR Sample Preparation, and Measurement

Na2S was purchased from DoJindo (SB01, Munich, Germany), and the other chemicals were purchased from Sigma-Aldrich (Steinheim, Germany). Na2S dissociates in the solution and reacts with H+ to yield H2S, HS, and traces of S2−. We used H2S to refer the total mixture of H2S, HS, and S2−. A stock solution of 100 mmol L−1 Na2S was prepared in argon-bubbled ultrapure deionized H2O, and was stored at −80 °C for a few days and used immediately after thawing.
Two selenium derivatives, 1-methyl-4-(3-(phenylselanyl)propyl)piperazine (RSe-1) and 1-methyl-4-(4-(phenylselanyl)butyl)piperazine (RSe-2), were obtained according to the synthesis routes shown in Scheme 1; Scheme 2. For the compound RSe-1, methyl piperazine was alkylated, employing 1-bromo-3-chloropropane in the presence of anhydrous K2CO3 and acetone as a solvent. The reaction was performed at room temperature (RT) and the progress of the reaction was controlled by thin layer chromatography. The crude product was used for Se-alkylation in absolute ethanol under a nitrogen atmosphere at room temperature (Scheme 1). For the compound RSe-2, Se-alkylation of 1-bromo-4-chlorobutane was performed under a nitrogen atmosphere and in absolute ethanol at RT. The crude product was then reacted with methyl piperazine in the presence of anhydrous K2CO3 and acetone at 50 °C (Scheme 2) [19]. The structure and purity of the final compounds were confirmed via spectroscopic and chromatographic methods. The final products were converted into crystalline hydrochloric salts to improve their solubility in water.
The spin-trapping agent, 5-tert-butoxycarbonyl-5-methyl-1-pyrroline N-oxide (BMPO, DoJindo B568, Munich, Germany), was dissolved in ultrapure deionized H2O (100 mmol L−1), stored at −80 °C, and used after thawing. For the EPR samples, a buffer consisting of 50 mmol L−1 sodium phosphate and 100 µmol L−1 diethylenetriaminepentaacetic acid (DTPA; pH 7.4; 37 °C) was used. Powdered KO2 (Sigma-Aldrich 278904, Steinheim, Germany) in amounts of 0.5–1 mg was weighed into tubes just before being used. As the dissolution of KO2 in a phosphate buffer shifts from pH to alkaline values, an adequate volume of 1 mol L−1 HCl was added to the buffer containing BMPO (20 mmol L−1) to get the required final pH after the addition to KO2. Twelve seconds after adding the BMPO-containing phosphate solution to the powdered KO2, compounds Na2S in H2O and RSe-1 or RSe-2, prepared in the buffer, were added. The pH in the samples was measured by pH indicator paper (Ahlstrom-Munksjö, Germany) with an accuracy of ±0.2. The detailed procedure for the sample preparation for EPR measurement is described in the Supplementary Materials. The sample was transferred to a standard cavity aqueous EPR flat cell (WG 808-Q, Wilmad-LabGlass, Vineland, NJ, USA), and the EPR spectra were measured as described previously [6]. The first EPR spectrum was recorded 100 ± 15 s after the addition of the BMPO solution to powdered KO2. The sets of individual EPR spectra of the BMPO spin adducts were recorded as 15 or 30 sequential scans of 42 s each, with a total acquisition time of 11 or 22 min, respectively. The EPR spectra of the BMPO spin adducts were measured on a Bruker EMX spectrometer (Rheinstetten, Germany) essentially as in our previous study [6]. All of the EPR spectra were recorded at 37 °C. The spectra were simulated using the EasySpin program working on the MatLab platform [20]. The concentration of BMPO-OOH and BMPO-OH radicals was evaluated from a double integral of their EPR spectra and compared with the spectra of 20 µmol L−1 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl radical (TEMPOL, Fluka 42777, Munich, Germany), which was used as a reference sample. To compare the potency of the investigated compounds for decreasing the overall trapped radical concentration, a double integral of the total EPR spectra intensity of the BMPO adducts was evaluated. The concentration of H2O2 was measured by a Fluorimetric Hydrogen Peroxide Assay Kit (MAK165, Merck, Bratislava, Slovakia) according to the manufacturer’s instructions. The concentrations of KO2 and the BMPO/KO2 mixture were diluted 1000 and 2000 times, respectively, before the measurement of H2O2.

2.2. Plasmid DNA (pDNA) Cleavage Assay

A pDNA cleavage assay with the use of the pBR322 plasmid (N3033 L, New England BioLabs, Inc., Ipswich, MA, USA) was performed as reported previously, with some modifications [6]. All of the final samples contained the studied compounds and 0.2 μg of pDNA in 20 µL of the sodium phosphate buffer (25 mmol L−1 sodium phosphate, 50 μmol L−1 DTPA; pH 6.5, 7.4, 8.0, or 8.5). The procedure for the sample preparation of the pDNA cleavage assay is described in detail in the Supplementary Materials. Likewise, in the EPR sample preparation, the phosphate buffer was adjusted by HCl to keep the final pH at the required value after being added to powdered KO2 (20 mmol L−1) (see Procedure 5 in Supplementary Materials). In the procedure focused on the KO2−BMPO interaction, the powdered KO2 (20 mmol L−1) was dissolved by 10 mmol L−1 BMPO in a 45 mmol L−1 phosphate buffer adjusted by HCl, then vortexed for 10 s, and 10 µL of the mixture was added to a 10 µL solution of pDNA in a 5 mmol L−1 phosphate buffer (see Procedure 6 in Supplementary Materials). The pH conditions were also standardized in the cleavage assay through the addition of 0.5 mol L−1 NaOH (for pH 6.5) or 0.1/0.125 mol L−1 HCl (for pH 8.0/8.5) to the pDNA solution to reach pH 7.4 for all of the samples (see Procedure 7 in Supplementary Materials).
For the preparation of the BMPO/KO2 mixture, in which, according to EPR experiments, BMPO-OOH/OH radicals were not formed, powdered KO2 (20 mmol L−1) was dissolved in a 50 mmol L−1 phosphate buffer adjusted by HCl, vortexed for 10 s, and then BMPO (10 mmol L−1) was added. As in the previous experiments, 10 µL of the mixture was added to 10 µL of the pDNA solution (see Procedure 8 in Supplementary Materials). All of the final samples contained 5 mmol L−1 BMPO and 10 mmol L−1 KO2 in the sodium phosphate buffer (25 mmol L−1 sodium phosphate, 50 μmol L−1 DTPA; pH 6.5, 7.4, 8.0 or 8.5). FeCl2 (150 µmol L−1), as a massive pDNA cleavage inductor, was used as a positive control in the assay. The resulting mixtures were incubated for 30 min at 37 °C. After incubation, the reaction mixtures were subjected to 0.6% agarose gel electrophoresis. The integrated densities of all pBR322 forms in each lane were quantified using Image Studio analysis software (LI-COR Biotechnology, Bad Homburg, Germany) to estimate the pDNA cleavage potency through the relative intensities (IR) of the nicked form of pDNA (see Figure S2 in Supplementary Materials).

3. Results

3.1. pH-Dependent Composition of BMPO-Adducts of (BMPO+HCl)-KO2 Interaction

In the control experiment, a phosphate buffer adjusted with HCl was added to powdered KO2 (final 40 mmol L−1 KO2) to get a final pH value of 7.4. After 10–13 s, when BMPO (final 20 mmol L−1) was added to the KO2–buffer solution, the EPR spectra of BMPO adducts were not observed (for details, see Procedure 1 in Supplementary Materials). However, when BMPO (20 mmol L−1) in a phosphate buffer (pH 7.4) was added to powdered KO2 (final 40 mmol L−1), EPR spectra, depending on final pH, were observed (Figure 1). After the BMPO-containing phosphate solution (pH 7.4) was added to the powdered KO2, the pH increased to ~10–11. Therefore, to study the pH dependence of the radical formation from KO2, HCl was added to BMPO in the buffer, which ensured that after the BMPO solution was added to the powdered KO2, the final required pH was obtained (for details, see Procedure 2 in Supplementary Materials). The intensity and shapes of the BMPO adducts spectra depended on the pH. The spectral intensity of BMPO adducts obtained at pH 9.0 decreased in time (Figure 1a1–a3). In comparison with pH 9.0, the EPR spectral intensity of the BMPO adducts at pH 7.7 was higher with a different relative abundance of individual species and slow decay of the adducts. The BMPO adducts were observed for more than 22 min at pH 7.7 (Figure 1b1–c3). A similar effect on the spectra of the BMPO adducts was also observed at pH 6.5 (Figure 1d1–e3) and pH 2 (Figure 1f1–g3). By comparison, the intensity of the EPR spectra of the BMPO adducts formed in the mixture of 5 mmol L−1 BMPO and 10 mmol L−1 KO2 at pH 7.4 was quantitatively lower (Figure 1h1–h3), but similar to that of the higher BMPO–KO2 concentration (Figure 1b1–e3). The stable nitroxide radical TEMPOL (20 µmol L−1) was used to determine the concentration of the radicals in the samples (Figure 1i1–i3). Using the double integrals of the TEMPOL calibration, the concentration of the total BMPO adduct radicals was high at pH 6.5–7.8 and low at pH 9.0–11.5, and decreased in time, with a halftime (pH 6.5–7.8) of approximately ~12 min (Figure 2a).
As described in detail in Section 3.2, the first recorded spectrum was simulated to obtain the individual components of BMPO-OOH (sum of conformers 1 and 2) and BMPO-OH (sum of conformers 1 and 2) at 100 ± 15 s after the sample preparation (Figure 2b). The ratio of the component population significantly depended on the pH; the portions of BMPO-OOH and BMPO-OH were ~95% and ~5%, respectively, of the whole concentration within a pH of ~2–8, and ~10% and ~90% within a pH of ~9–11.
As H2O2 is produced during the reaction of KO2 with H2O, its concentration was measured in samples containing KO2 at pH 7.4. H2O2 concentrations of 8.9 ± 1.4 (n = 4) and 10.5 ± 0.7 (n = 4) mmol L−1 were formed after the addition of buffer + HCl or BMPO + HCl to the powdered KO2 (final 20/40 BMPO/KO2 in mmol L−1), respectively.

3.2. Simulation of EPR Spectra of pH-Dependent BMPO Adducts

The shapes of the EPR spectra of the BMPO adducts depended on the pH (Figure 1) and changed over time, indicating a dynamic superposition of signals corresponding to the generation of individual BMPO adducts. Therefore, we analyzed the EPR spectra by simulation, as in [6]. Two conformers each of BMPO-OOH and BMPO-OH adducts were inserted into the spin Hamiltonian calculations of the experimental spectra measured in the pH range of 2–8. However, in the EPR spectra measured in the solutions at pH ≥ 9, two additional low-intensity six-line signals were detected, which were assigned to the BMPO adduct with a carbon-centered radical (BMPO-CR) [8] and BMPO-CO2, most likely originating from the DTPA decomposition in the alkaline solutions. The simulated spectra shown in Figure 3 were calculated using the hyperfine coupling constants (hfcc) elucidated from the experimental spectra (Table 1). The comparison of the experimental and simulated spectra shows a good fit when using the hfcc. The detailed simulation analysis of the hfcc of the individual BMPO adducts evaluated from the EPR spectra measured at various pH values revealed only a negligible pH effect on the hfcc.

3.3. Comparison of pH-Dependent BMPO Adduct Spectra of BMPO−KO2 Interaction

For simplicity, the relative concentrations of two conformers, BMPO-OH(1) and BMPO-OH(2), were summed and described as BMPO-OH. Analogously, BMPO-OOH(1) and BMPO-OOH(2) were summed and described as BMPO-OOH. As described in Section 3.1, the pH-dependent formation of individual BMPO-OOH and BMPO-OH components elucidated from the simulation of the first experimental EPR spectrum is shown in Figure 2b. The time dependence of the EPR intensity of the simulated components of 1–5, 6–10, and 11–15 accumulated experimental BMPO adduct spectra at different pH values is shown in Figure 4. The sum of individual BMPO adducts of the accumulated spectra at a given time was normalized to 100%. At pH 11.5, the BMPO-OH component decreased in time, and BMPO-CR and BMPO-CO2 components were present (Figure 4a). Similarly, mostly BMPO-OH, as well as a minor abundance of BMPO-CR, BMPO-CO2, and BMPO-OOH components, were observed at pH 9.0 (Figure 4b). However, at a lower pH (≤8.0), the BMPO-OOH component prevailed over BMPO-OH (Figure 4c,d,e,g). The relative concentration of BMPO-OOH decreased and BMPO-OH increased gradually over time at pH 7.7–8.0 (Figure 4c–e). The relative concentration of BMPO-OOH in comparison with BMPO-OH was high at pH 6.0 and relatively stable for over 11 min (Figure 4g,h).
To compare the pH dependence of the total radicals of the BMPO adduct components, double integral intensities of the simulated spectra were applied (Figure 5). The concentration of trapped radicals of the BMPO adducts was very low at pH ~9.0–11.5 (Figure 5a,b). However, at pH ~6.0–8.0, the number of trapped radicals increased ~3–10 times, particularly because of the BMPO-OOH component (Figure 5c–h). The amount of BMPO-OOH radical components was ~10 times higher in comparison with BMPO-OH at pH ~6.0–8.0, 3.5 min after the sample preparation (Figure 5c–h). The presence of the BMPO-OOH component was still ~3 times more abundant in comparison with BMPO-OH after 22 min at pH ~6.0 (Figure 5h).

3.4. Effect of Na2S and Selenium Derivatives on BMPO-OOH/OH Radicals

The spectral intensity and shape of the BMPO adducts depended on the time and compounds added to the samples at pH 7.4 and 6.7 (Figure 6 and Figure 7). The spectral intensity of BMPO adducts for all of the samples decayed over time and was visible for more than 22 min (Figure 6 and Figure 7). However, at pH 6.7, the decay in RSe-1 and RSe-2 was complex, and was not further investigated in detail (Figure 7). Na2S (100 µmol L−1) decreased the total concentration of BMPO adducts in comparison with the controls (Figure 6c1–d3, Figure 7b1–b3 and Figure 8a. The effect of RSe-1 and RSe-2 on the total concentration of BMPO-adducts was not significantly different from the control spectra at pH 7.4 (Figure 8a). A comparison of the effect of the compounds on the total BMPO adduct concentration of the first recorded spectrum at pH 6.5–8.0 is shown in Figure 8b. The concentrations of BMPO adducts were high for the controls at pH 6.5–8.0. Na2S (100 µmol L−1) decreased the spin adduct concentration, whereas the effects of RSe-1 and RSe-2 were not significantly different compared with the controls at pH 7.4.
The experimental spectra were simulated as previously described (Section 3.2), and revealed BMPO-OOH and BMPO-OH components (Figure 9). In the controls (pH 7.4 and 6.7), BMPO-OOH slightly decreased in time, but prevailed over BMPO-OH, which slightly increased for 22 min (Figure 9a,e). The simulation data for RSe-1 and RSe-2 (Figure 9c,d,g,h) were calculated from the experimental spectra shown in Figure 6 and Figure 7. Interestingly, RSe-1 and RSe-2, which did not change the total radical concentrations compared with control spectra at pH 7.4 (Figure 8a), significantly decreased BMPO-OOH and increased the BMPO-OH components over time, reaching equilibrium in 15–22 min at pH 7.4 (Figure 9c,d) and in 9–10 min at pH 6.7 (Figure 9g,h). Na2S decreased BMPO-OOH and increased the BMPO-OH components in time, similar to RSe-1 and RSe-2 at 7.4 pH, but had a minor effect at pH 6.7 (Figure 9b,f).
The first recorded spectrum at 100 ± 15 s after the sample preparation was obtained through spectrum simulation, as described in Section 3.2 (Figure 10). The control BMPO-OOH component within pH 6.7–8.0 was ~95–98% and BMPO-OH was ~2–5% of the total BMPO adducts. At pH 9.0, the ratio was the opposite. The BMPO-OOH component within pH 6.7–8.0 decreased to ~75–90% and BMPO-OH increased to ~10–25% in the samples with Na2S, RSe-1, and RSe2 compared with the controls (Figure 10). The results confirm that the studied compounds started to influence the BMPO-OOH/OH radicals early after the sample preparation.

3.5. Composition of BMPO Adducts of BMPO−KO2 Mixture after Addition of HCl

A different procedure for BMPO adduct preparation was also used. In this procedure, the BMPO solution was added to powdered KO2, and 30 s later, the pH was adjusted by HCl to the required value. For details of the sample preparation, see Procedure 4 in the Supplementary Materials. The pH dependence of the BMPO adduct spectra showed significant differences (Figure 11 and Figure 12) compared with the spectra observed in Figure 1, Figure 3 and Figure 4 when HCl was added to the BMPO solution before KO2. The spectra depended on the pH and increased/decreased over time for more than 22 min. In order to find the spectral components of the BMPO adducts of the samples prepared by the latter procedure, the EPR spectra were simulated as in the previous cases (Section 3.2). A comparison of the experimental and simulated spectra at different pH values (Figure 12) showed that the best simulation fit was obtained using the hfcc (Table 1). The time dependence of the spectral intensity of the simulated components of BMPO adducts at different pH values is shown in Figure 13. The left and right columns show the relative and absolute proportions of the spectral components, respectively. At pH 10.3, BMPO-OH, BMPO-CR, and BMPO-CO2 adducts (but not BMPO-OOH) were observed (Figure 13a,f). The absolute value of the BMPO adduct radicals at pH 10.3 was low compared with that at pH 6.5–8.5. At pH 7.3–8.5, the component BMPO-OH increased in time and prevailed over BMPO-OOH, which decreased in time (Figure 13b,c,g,h). At pH 6.5, both BMPO-OOH/OH components were present in approximately equally amounts (Figure 13e,j).

3.6. pH-Dependent Cleavage of pDNA by BMPO–KO2 Interaction

To know whether BMPO adducts have biological effects, the cleavage of pDNA by BMPO-OOH/OH was evaluated (Figure 14 and Figure S2). pDNA cleavage was negligible in the control buffers at pH 6.5, 7.4, 8.0, and 8.5, but significantly increased in the presence of FeCl2, which is known to cleave DNA [21,22]. Besides the single-stranded cleavage of the supercoiled pDNA generating the nicked circular form, FeCl2 was notably able to mediate double-stranded cleavage, creating linear form (Figure S2 in Supplementary Materials). The control samples containing BMPO, H2O2, KO2, or the mixture of H2O2 and KO2 did not induce pDNA cleavage. However, when BMPO + HCl was added to powdered KO2, producing BMPO-OOH/OH, and then applied to pDNA, significant pDNA cleavage was observed at all of the pH values studied. The values were scattered, but the pDNA cleavage potency had a tendency to increase with the increasing pH values. To confirm the involvement of pH in the observed effect, the solution of pDNA in the phosphate buffer was adjusted by NaOH or HCl to standardize the pH to 7.4 after the addition of (BMPO + HCl) + KO2 solutions with pH 6.5, 8.0, and 8.5. After the pH was adjusted to 7.4, the effects of the mixtures were still significant, but the pH trend was lost. Based on the EPR measurement of the radical concentration, pDNA was significantly cleaved by BMPO-OOH/OH at a concentration of ~18 µmol L−1, where the concentration ratio of BMPO-OOH to BMPO-OH at the beginning of the experiments was ≥20. Taking into consideration the short lifespan of O2•− in an aqueous solution, we prepared a control sample that, according to the EPR study, did not form radicals, as follows: first, powdered KO2 was dissolved in a phosphate buffer adjusted with HCl to get a 20 mmol L−1 KO2 solution with a corresponding pH, then, 10 s later BMPO (final 10 mmol L−1) was added, and this mixture was applied at 1:1 volume ratio to pDNA solution. In accordance with the EPR data, the mixture prepared in this way had a negligible effect on the pDNA cleavage at all of the pH levels used (Figure 14).

4. Discussion

O2•− and its derivatives are involved in radical signaling and, more significantly, in the development of diseases due to oxidative stress-mediated damage of the cellular structures [1,2]. To study the molecular mechanism of its biological actions, it is convenient to have a simple and reproducible source of O2•−. There are several methods to produce O2•− [3]; however, some of them are not experimentally simple or are not suitable for biological experiments. Therefore, KO2 as a source of O2•− was studied by the EPR spin trapping method without using non-biological components. As in our aqueous experimental system the O2•− is highly reactive and spontaneously disproportionates within 10 s, this study was limited mostly to monitoring the secondary radicals (spin adducts) BMPO-OOH/BMPO-OH, and did not study the production rates and fate of any primary radicals. Additionally, we are conscious of the pH-dependent reactivity of HO2/H2O2 produced in the O2•− disproportionation in the process of BMPO adduct generation.
The dissolution of KO2 by a phosphate buffer produces O2•− and H2O2. O2•− is known to form BMPO-OOH or BMPO-OH radicals, which are detectable by EPR and can be obtained by spectral simulation. From the good fit of the experimental spectra, it is obvious that the hfcc are suitable for spectral simulation. The hfcc values are in the range of data obtained under similar experimental conditions [4,6,8,9,11]. As our method distinguishes concentrations of the time-dependent changes of BMPO-OOH and BMPO-OH radicals in the same sample, it is appropriate for time-dependent studies of compound interactions with radicals. In BMPO-OOH and BMPO-OH nitroxide (aminoxyl) radicals, the unpaired electron is mostly localized on the N-O moiety and the hyperfine interactions with nitrogen and β-hydrogen nuclei dominate the EPR spectra (Table 1). Therefore, BMPO-OOH and BMPO-OH can be further studied as potential models of organic hydroperoxide and alcohol, respectively.
The dissolution of KO2 in a water solution (e.g., pH 7.4) produces O2•− with a short lifetime (<ms) [3,7,23]. This was confirmed under our experimental conditions at pH 7.4, in which spin trap BMPO added 10–13 s after the preparation of the buffer/KO2 solution did not show any BMPO-adduct spectra. The same result was found when KO2 in DMSO was added to a pH 7.4 buffered water solution followed by BMPO [6].
Using the spin trap BMPO, we observed that the addition of a water solution to powder KO2 produced radicals, whose composition and intensity significantly depended on the pH level during the dissolution of KO2. As KO2 is a strong base, the addition of a buffered water solution (50 mmol L−1 phosphate buffer, pH 7.4) to powdered KO2 (final 40 mmol L−1) increased the pH to 10–11. There are two possible ways to decrease the pH of the mixture to the physiological value of 7.4. When pH was decreased to 6.5–8.5 through the addition of HCl to the prepared BMPO/KO2 mixture, BMPO-OH radicals, compared with BMPO-OOH, were mostly observed at pH ~7.3–10.3 (Figure 13). On the other hand, when the BMPO solution adjusted with HCl was added to the powdered KO2 to get a final physiological pH of ~6–8, BMPO-OOH prevailed over BMPO-OH (Figure 2b, Figure 4 and Figure 10). The BMPO-OOH/BMPO-OH ratio calculated from the first recorded EPR spectrum was ≥20 (Figure 2b). As the first spectrum was recorded 100 ± 15 s after the BMPO–HCl solution was mixed with powdered KO2, it is very probable that the BMPO-OOH/OH ratio was even higher immediately after the sample preparation. Based on these data, it can be suggested that KO2 can be used as a source of O2•− and BMPO-OOH, when it is ensured that during the dissolution of KO2, the pH is within the range of 6.5–8.0. This can be done by applying acid during the dissolution or by using a strong physiological buffer. However, as a significant amount of H2O2 is produced during the dissolution of KO2 by an aqueous buffer, its involvement in radical–compound interactions should be also taken into account.
It is supposed that the observed hydroxyl adduct, BMPO-OH, was mostly produced by pH- and time-dependent decomposition of BMPO-OOH, which was formed by trapping O2•− during KO2 dissolution. This suggestion is supported by the time- and pH-dependent progressive increase in the relative concentration of BMPO-OH, which is more stable than BMPO-OOH, upon a progressive decrease in the BMPO-OOH relative concentration (Figure 2b and Figure 10). The significant proportion of the BMPO-OH component in the first recorded spectrum at pH ≥ 9.0 correlated well with published data [8]. However, the intensity of the BMPO-OH spectra transiently increased over time in the mixture of BMPO + H2O2 (pH 9.0 and 12.2; Figure S1), suggesting that the BMPO/H2O2 interaction contributed to the BMPO-OH component. Additionally, the decomposition of H2O2 into reactive oxygen species under alkaline media may promote the production of BMPO-OH [24,25,26,27]. As the present study was focused mainly on the practical preparation of BMPO-OOH, the mechanism of hydroxyl adduct formation was not studied in more detail.
Our previous study described the preparation of the BMPO-OOH spin adduct as a model for the study of organic hydroperoxide decomposition [6]. We used 10% DMSO (v/v) to prepare the BMPO adduct, which is useful for evaluating the antioxidant potency and effects of compounds insoluble in water on BMPO-OOH. In the present study, BMPO-OOH, as a potential model of hydroperoxide, was prepared without DMSO, and the antioxidant potency of compounds soluble in water, such as H2S, RSe-1, and RSe-2, was studied. As in our previous study with H2S in a 10% DMSO solvent [6,22], the water solution of H2S changed the BMPO-OOH/BMPO-OH proportion and decreased the overall radical concentrations. RSe-1 and RSe-2 interacted with BMPO adducts and increased the radical proportion of BMPO-OH over BMPO-OOH in a time-dependent manner, even in the case when the total time-dependent BMPO adducts were similar to the controls. The detailed mechanism of the chemical interactions leading to changes in the concentration and/or ratio of BMPO-OOH/OH is not known at present and requires further examination.
The oxidation of DNA occurs through reactions with reactive oxygen species (ROS), e.g., HO, O2•−, singlet oxygen (1O2), peroxynitrite (ONOO), or H2O2, which are produced during endogenous biological processes [28,29,30]. Therefore, pDNA was used to test the biological effects of BMPO adducts. pDNA was significantly cleaved by low BMPO-OOH/BMPO-OH concentrations, in which BMPO-OOH prevailed over BMPO-OH. BMPO, KO2, H2O2, and KO2 + H2O2 alone did not cleave pDNA, indicating that they were not involved in the pDNA cleavage effects of BMPO-OOH/BMPO-OH. The mixture prepared for 10 s, which delayed the addition of BMPO to the buffer + HCl + KO2 solution, which did not form a BMPO adduct spectral signal, also did not cleave pDNA, confirming that neither the components of the mixture nor their nonradical products were able to cleave pDNA. Altogether, this implies that BMPO-OOH/OH radicals are responsible for pDNA cleavage. A detailed cascade of the chemical interactions leading to pDNA cleavage by BMPO-OOH/OH radicals is not known at the present and remains to be elucidated.

5. Conclusions

This study utilized KO2 as a source of O2•− radical anions and the EPR spin trapping technique with BMPO to monitor the generation of the BMPO-OOH spin adduct and its conversion to BMPO-OH in a water solution without DMSO as a potential model for organic hydroperoxides and alcohols. The concentration and relative abundance of BMPO-OOH and BMPO-OH elucidated from the EPR spectra strongly depended on the procedure of the sample preparation and the pH value. In the pH range of 6.5–8.0, BMPO-OOH predominated over BMPO-OH. Moreover, the method also distinguished the time-dependent concentration changes of both BMPO adducts in the same sample, so it is appropriate for studies of time-dependent interactions of compounds with radicals. The BMPO-OOH/OH radicals cleaved the plasmid DNA. H2S and selenium-containing derivatives increased the proportion of BMPO-OH over BMPO-OOH radicals. This demonstrates that the presented approach can be used to study the biological effects of BMPO-OOH/OH radicals and the interactions of compounds with BMPO-OOH/OH.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/antiox10081286/s1, Procedures for preparation of EPR samples. Figure S1: Time- and pH-dependent EPR spectra of BMPO adducts of the 30 mmol L−1 BMPO in the presence of 1 and 10 mmol L−1 H2O2. Figure S2: Representative gels indicating the effects of BMPO−KO2 interaction on pDNA cleavage at various pH.

Author Contributions

Conceptualization, K.O.; formal analysis, A.M., V.B. and K.L.; investigation, A.M., V.B., M.C., K.L., M.G. and K.O.; methodology, A.M., V.B., M.C. and K.O.; project administration, M.C. and K.O.; resources, K.L., M.J.N. and C.J.; supervision, K.O.; validation, V.B., M.C., M.J.N., M.G., L.T. and K.O.; visualization, A.M., V.B., M.C., M.G., L.T. and K.O.; writing—original draft, K.O. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Slovak Research and Development Agency, grant number APVV-19-0154 to K.O. and APVV-17-0384 to M.C., and the Scientific Grant Agency of the Slovak Republic, grant number VEGA 1/0064/21 to V.B., 2/0079/19 to M.G., 2/0091/21 to A.M., and 2/0053/19 to M.C. V.B. thanks Ministry of Education, Science, Research and Sport of the Slovak Republic for funding within the scheme “Excellent research teams”.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

All findings and conclusions are based on the presented figures in the main text or in the Supplementary Materials. Original source files can be sent from the corresponding author, Dr. Karol Ondrias, upon request.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Carroll, L.; Pattison, D.I.; Davies, J.B.; Anderson, R.F.; Lopez-Alarcon, C.; Davies, M.J. Superoxide radicals react with peptide-derived tryptophan radicals with very high rate constants to give hydroperoxides as major products. Free Radic. Biol. Med. 2018, 118, 126–136. [Google Scholar] [CrossRef]
  2. Chiste, R.C.; Freitas, M.; Mercadante, A.Z.; Fernandes, E. Superoxide Anion Radical: Generation and Detection in Cellular and Non-Cellular Systems. Curr. Med. Chem. 2015, 22, 4234–4256. [Google Scholar] [CrossRef] [PubMed]
  3. Hayyan, M.; Hashim, M.A.; AlNashef, I. Superoxide Ion: Generation and Chemical Implications. Chem. Rev. 2016, 116, 3029–3085. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Zhao, H.; Joseph, J.; Zhang, H.; Karoui, H.; Kalyanaraman, B. Synthesis and biochemical applications of a solid cyclic nitrone spin trap: A relatively superior trap for detecting superoxide anions and glutathiyl radicals. Free Radic. Biol. Med. 2001, 31, 599–606. [Google Scholar] [CrossRef]
  5. Bézière, N.; Hardy, M.; Poulhès, F.; Karoui, H.; Tordo, P.; Ouari, O.; Frapart, Y.-M.; Rockenbauer, A.; Boucher, J.-L.; Mansuy, D.; et al. Metabolic stability of superoxide adducts derived from newly developed cyclic nitrone spin traps. Free Radic. Biol. Med. 2014, 67, 150–158. [Google Scholar] [CrossRef] [Green Version]
  6. Misak, A.; Brezova, V.; Grman, M.; Tomasova, L.; Chovanec, M.; Ondrias, K. BMPO-OOH Spin-Adduct as a Model for Study of Decomposition of Organic Hydroperoxides and the Effects of Sulfide/Selenite Derivatives. An EPR Spin-Trapping Approach. Antioxidants 2020, 9, 918. [Google Scholar] [CrossRef]
  7. Janik, I.; Tripathi, G.N. The nature of the superoxide radical anion in water. J. Chem. Phys. 2013, 139, 014302. [Google Scholar] [CrossRef]
  8. Villamena, F.A.; Zweier, J.L. Superoxide radical trapping and spin adduct decay of 5-tert-butoxycarbonyl-5-methyl-1-pyrroline N-oxide (BocMPO): Kinetics and theoretical analysis. J. Am. Chem. Soc. Perkin Trans 1 2002, 1340–1344. [Google Scholar] [CrossRef]
  9. Tsai, P.; Ichikawa, K.; Mailer, C.; Pou, S.; Halpern, H.J.; Robinson, B.H.; Nielsen, R.; Rosen, G.M. Esters of 5-Carboxyl-5-methyl-1-pyrrolineN-Oxide: A Family of Spin Traps for Superoxide. J. Org. Chem. 2003, 68, 7811–7817. [Google Scholar] [CrossRef]
  10. Stolze, K.; Udilova, N.; Rosenau, T.; Hofinger, A.; Nohl, H. Synthesis and Characterization of EMPO-Derived 5,5-Disubstituted 1-Pyrroline N-Oxides as Spin Traps Forming Exceptionally Stable Superoxide Spin Adducts. Biol. Chem. 2003, 384, 493–500. [Google Scholar] [CrossRef]
  11. Tsai, P.; Marra, J.M.; Pou, S.; Bowman, M.K.; Rosen, G.M. Is There Stereoselectivity in Spin Trapping Superoxide by 5-tert-Butoxycarbonyl-5-methyl-1-pyrrolineN-Oxide? J. Org. Chem. 2005, 70, 7093–7097. [Google Scholar] [CrossRef]
  12. Spasojević, I. Free radicals and antioxidants at a glance using EPR spectroscopy. Crit. Rev. Clin. Lab. Sci. 2011, 48, 114–142. [Google Scholar] [CrossRef]
  13. Abbas, K.; Hardy, M.; Poulhès, F.; Karoui, H.; Tordo, P.; Ouari, O.; Peyrot, F. Detection of superoxide production in stimulated and unstimulated living cells using new cyclic nitrone spin traps. Free Radic. Biol. Med. 2014, 71, 281–290. [Google Scholar] [CrossRef]
  14. Chang, J.; Taylor, R.D.; Davidson, R.A.; Sharmah, A.; Guo, T. Electron Paramagnetic Resonance Spectroscopy Investigation of Radical Production by Gold Nanoparticles in Aqueous Solutions Under X-ray Irradiation. J. Phys. Chem. A 2016, 120, 2815–2823. [Google Scholar] [CrossRef]
  15. Suzen, S.; Gurer-Orhan, H.; Saso, L. Detection of Reactive Oxygen and Nitrogen Species by Electron Paramagnetic Resonance (EPR) Technique. Molecules 2017, 22, 181. [Google Scholar] [CrossRef] [PubMed]
  16. Olson, K.R. Hydrogen sulfide, reactive sulfur species and coping with reactive oxygen species. Free Radic. Biol. Med. 2019, 140, 74–83. [Google Scholar] [CrossRef]
  17. Corvino, A.; Frecentese, F.; Magli, E.; Perissutti, E.; Santagada, V.; Scognamiglio, A.; Caliendo, G.; Fiorino, F.; Severino, B. Trends in H2S-Donors Chemistry and Their Effects in Cardiovascular Diseases. Antioxidants 2021, 10, 429. [Google Scholar] [CrossRef] [PubMed]
  18. Di Leo, I.; Sancineto, L.; Messina, F.; Santi, C. Organoselenium compounds, an overview on the biological activities beyond antioxidant properties. In Proceedings of the 20th International Electronic Conference on Synthetic Organic Chemistry (ECSOC), online, 1–30 November 2016. [Google Scholar]
  19. Ali, W.; Spengler, G.; Kincses, A.; Nové, M.; Battistelli, C.; Latacz, G.; Starek, M.; Dąbrowska, M.; Honkisz-Orzechowska, E.; Romanelli, A.; et al. Discovery of phenylselenoether-hydantoin hybrids as ABCB1 efflux pump modulating agents with cytotoxic and antiproliferative actions in resistant T-lymphoma. Eur. J. Med. Chem. 2020, 200, 112435. [Google Scholar] [CrossRef] [PubMed]
  20. Stoll, S.; Schweiger, A. EasySpin, a comprehensive software package for spectral simulation and analysis in EPR. J. Magn. Reson. 2006, 178, 42–55. [Google Scholar] [CrossRef]
  21. Nagai, F.; Ushiyama, K.; Kano, I. DNA cleavage by metabolites of butylated hydroxytoluene. Arch. Toxicol. 1993, 67, 552–557. [Google Scholar] [CrossRef] [PubMed]
  22. Grman, M.; Misak, A.; Kurakova, L.; Brezova, V.; Cacanyiova, S.; Berenyiova, A.; Balis, P.; Tomasova, L.; Kharma, A.; Domínguez-Álvarez, E.; et al. Products of Sulfide/Selenite Interaction Possess Antioxidant Properties, Scavenge Superoxide-Derived Radicals, React with DNA, and Modulate Blood Pressure and Tension of Isolated Thoracic Aorta. Oxid. Med. Cell. Longev. 2019, 2019, 9847650. [Google Scholar] [CrossRef] [Green Version]
  23. Bielski, B.H.J.; Cabelli, D.E.; Arudi, R.L.; Ross, A.B. Reactivity of HO2/O2 Radicals in Aqueous Solution. J. Phys. Chem. Ref. Data 1985, 14, 1041–1100. [Google Scholar] [CrossRef]
  24. Galbács, Z.M.; Csányi, L.J. Alkali-induced decomposition of hydrogen peroxide. J. Chem. Soc. Dalton Trans. 1983, 2353–2357. [Google Scholar] [CrossRef]
  25. Csányi, L.J.; Nagy, L.; Galbács, Z.M.; Horváth, I. Alkali-Induced Generation of Superoxide and Hydroxyl Radicals from Aqueous Hydrogen Peroxide Solution. Z. Phys. Chem. 1983, 138, 107–116. [Google Scholar] [CrossRef]
  26. Dong, D.; Vandegrift, G.F. Alkaline Peroxide Processing of Low-Enriched Uranium Targets for 99Mo Production—Decomposition of Hydrogen Peroxide. Nucl. Sci. Eng. 1997, 126, 213–223. [Google Scholar] [CrossRef]
  27. Miller, C.M.; Valentine, R.L. Mechanistic studies of surface catalyzed H2O2 decomposition and contaminant degradation in the presence of sand. Water Res. 1999, 33, 2805–2816. [Google Scholar] [CrossRef]
  28. Loft, S.; Poulsen, H.E. Cancer risk and oxidative DNA damage in man. J. Mol. Med. 1996, 74, 297–312. [Google Scholar] [CrossRef]
  29. Miura, T. The peroxidase activity of ADM-Fe3+ cooperates with lipid peroxidation: The participation of hydroperoxide and hydroxyl radicals in the damage to proteins and DNA. Chem. Biol. Interact. 2015, 236, 67–73. [Google Scholar] [CrossRef] [PubMed]
  30. Jiang, D.; Rusling, J.F. Oxidation Chemistry of DNA and p53 Tumor Suppressor Gene. ChemistryOpen 2019, 8, 252–265. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Scheme 1. Synthesis of compound RSe-1. (a)The first step of synthesis involves the alkylation of 1-methylpiperazine with 1-bromo-3-chlropropane to produce 1-(3-chloropropyl)-4-methylpiperazine in the presence of K2CO3 and acetone at room temperature. (b) 1-(3-chloropropyl)-4-methylpiperazine is subsequently reacted with diphenyl diselenide in an inert environment of N2, in the presence of NaBH4 and absolute ethanol at room temperature to obtain RSe-1 as final product.
Scheme 1. Synthesis of compound RSe-1. (a)The first step of synthesis involves the alkylation of 1-methylpiperazine with 1-bromo-3-chlropropane to produce 1-(3-chloropropyl)-4-methylpiperazine in the presence of K2CO3 and acetone at room temperature. (b) 1-(3-chloropropyl)-4-methylpiperazine is subsequently reacted with diphenyl diselenide in an inert environment of N2, in the presence of NaBH4 and absolute ethanol at room temperature to obtain RSe-1 as final product.
Antioxidants 10 01286 sch001
Scheme 2. Synthesis of compound RSe-2. (a)The first step of synthesis involves the Se-alkylation of 1-bromo-4-chlorobutane with diphenyl diselenide in an inert environment of N2, in the presence of NaBH4 and absolute ethanol at room temperature to obtain (4-chlorobutyl)(phenyl)selane. (b) In the second step (4-chlorobutyl)(phenyl)selane is reacted with 1-methylpiperazine in the presence of K2CO3 and acetone at room temperature to obtain RSe-2 as final product.
Scheme 2. Synthesis of compound RSe-2. (a)The first step of synthesis involves the Se-alkylation of 1-bromo-4-chlorobutane with diphenyl diselenide in an inert environment of N2, in the presence of NaBH4 and absolute ethanol at room temperature to obtain (4-chlorobutyl)(phenyl)selane. (b) In the second step (4-chlorobutyl)(phenyl)selane is reacted with 1-methylpiperazine in the presence of K2CO3 and acetone at room temperature to obtain RSe-2 as final product.
Antioxidants 10 01286 sch002
Figure 1. Representative pH-dependent EPR spectra of BMPO adducts after the addition of 20 mmol L−1 BMPO + HCl to powdered KO2 (final 40 mmol L−1 KO2). (a1i1) Collection of 15 EPR spectra of BMPO adducts arranged back-to-back, each 42 s, with a starting acquisition of 100 ± 15 s after sample preparation. (a2i2) The first to fifth accumulated spectra and (a3i3) last five accumulated spectra. HCl was added to BMPO (20 mmol L−1) in a buffer for the final required pH and the solution was added to powdered KO2. (a1a3) pH 9.0; (b1b3) pH 7.7 and (c1c3) continuation; (d1d3) pH 6.5 and (e1e3) continuation; (f1f3) pH 2.0 and (g1g3) continuation. (h1h3) BMPO adducts after the addition of 5 mmol L−1 BMPO + HCl to powdered KO2 (final 10 mM KO2) at pH 7.4. (i1i3) The EPR spectra of stable radical TEMPOL (20 µmol L−1). Intensities of (a1h1) time-dependent EPR spectra and (a2h3) the detailed spectra are approximately comparable. For details of the sample preparation, see Procedure 2 in Supplementary Materials.
Figure 1. Representative pH-dependent EPR spectra of BMPO adducts after the addition of 20 mmol L−1 BMPO + HCl to powdered KO2 (final 40 mmol L−1 KO2). (a1i1) Collection of 15 EPR spectra of BMPO adducts arranged back-to-back, each 42 s, with a starting acquisition of 100 ± 15 s after sample preparation. (a2i2) The first to fifth accumulated spectra and (a3i3) last five accumulated spectra. HCl was added to BMPO (20 mmol L−1) in a buffer for the final required pH and the solution was added to powdered KO2. (a1a3) pH 9.0; (b1b3) pH 7.7 and (c1c3) continuation; (d1d3) pH 6.5 and (e1e3) continuation; (f1f3) pH 2.0 and (g1g3) continuation. (h1h3) BMPO adducts after the addition of 5 mmol L−1 BMPO + HCl to powdered KO2 (final 10 mM KO2) at pH 7.4. (i1i3) The EPR spectra of stable radical TEMPOL (20 µmol L−1). Intensities of (a1h1) time-dependent EPR spectra and (a2h3) the detailed spectra are approximately comparable. For details of the sample preparation, see Procedure 2 in Supplementary Materials.
Antioxidants 10 01286 g001
Figure 2. (a) Time and pH dependencies of the total BMPO adduct radical concentration of the BMPO + HCl/KO2 (20/40 in mmol L−1) mixture. Each point represents the average of five accumulated subsequent EPR spectra. Time starts after the addition of BMPO + HCl to powdered KO2. (b) pH-dependent normalized integral EPR intensity of individual BMPO-OOH and BMPO-OH components elucidated from the simulation of the first experimental EPR spectrum recorded 100 ± 15 s after the addition of BMPO + HCl to powdered KO2. Spectral simulation is described in Section 3.2. Spectral components: BMPO-OOH (blue) and BMPO-OH (red). The sum of individual BMPO adducts of the first spectra was normalized to 100%. Each pair (blue and red) of two complementary points represents the individual sample preparation.
Figure 2. (a) Time and pH dependencies of the total BMPO adduct radical concentration of the BMPO + HCl/KO2 (20/40 in mmol L−1) mixture. Each point represents the average of five accumulated subsequent EPR spectra. Time starts after the addition of BMPO + HCl to powdered KO2. (b) pH-dependent normalized integral EPR intensity of individual BMPO-OOH and BMPO-OH components elucidated from the simulation of the first experimental EPR spectrum recorded 100 ± 15 s after the addition of BMPO + HCl to powdered KO2. Spectral simulation is described in Section 3.2. Spectral components: BMPO-OOH (blue) and BMPO-OH (red). The sum of individual BMPO adducts of the first spectra was normalized to 100%. Each pair (blue and red) of two complementary points represents the individual sample preparation.
Antioxidants 10 01286 g002
Figure 3. Representative normalized experimental EPR spectra of BMPO adducts along with their simulations using the hfcc summarized in Table 1. Only the experimental spectra of the sixth to tenth accumulated spectra are shown (blue, measured 5.2–8.7 min after sample preparation); the simulated spectra are red. (a) pH 9.0, (b) pH 7.7, (c) continued measurement during 15.7–19.2 min, and (d) pH 6.0.
Figure 3. Representative normalized experimental EPR spectra of BMPO adducts along with their simulations using the hfcc summarized in Table 1. Only the experimental spectra of the sixth to tenth accumulated spectra are shown (blue, measured 5.2–8.7 min after sample preparation); the simulated spectra are red. (a) pH 9.0, (b) pH 7.7, (c) continued measurement during 15.7–19.2 min, and (d) pH 6.0.
Antioxidants 10 01286 g003
Figure 4. Comparison of time and pH-dependent normalized integral EPR intensity of individual BMPO adducts elucidated from the simulation of experimental EPR spectra. Spectral components: BMPO-OOH (blue), BMPO-OH (red), BMPO-CR (black), BMPO-CO2- (green) at (a) pH 11.5 (pH was adjusted by NaOH), (b) pH 9.0, (c) pH 8.0, (d) pH 7.8, and (e) pH 7.7; (f) continued measurement of (e) for the next 11 min; (g) pH 6.0 and (h) continued measurement of (g) for the next 11 min. Each point represents the average of five accumulated subsequent EPR spectra. Time starts after the addition of BMPO + HCl to powdered KO2. The sum of individual BMPO adducts of accumulated spectra was normalized to 100%. For details of the sample preparation, see Procedure 2 in Supplementary Materials.
Figure 4. Comparison of time and pH-dependent normalized integral EPR intensity of individual BMPO adducts elucidated from the simulation of experimental EPR spectra. Spectral components: BMPO-OOH (blue), BMPO-OH (red), BMPO-CR (black), BMPO-CO2- (green) at (a) pH 11.5 (pH was adjusted by NaOH), (b) pH 9.0, (c) pH 8.0, (d) pH 7.8, and (e) pH 7.7; (f) continued measurement of (e) for the next 11 min; (g) pH 6.0 and (h) continued measurement of (g) for the next 11 min. Each point represents the average of five accumulated subsequent EPR spectra. Time starts after the addition of BMPO + HCl to powdered KO2. The sum of individual BMPO adducts of accumulated spectra was normalized to 100%. For details of the sample preparation, see Procedure 2 in Supplementary Materials.
Antioxidants 10 01286 g004
Figure 5. Comparison of pH-dependent absolute integral EPR intensity (total quantity of radicals in r.u.) of individual BMPO adducts elucidated from the simulation of the experimental EPR spectra. Spectral components: BMPO-OOH (blue), BMPO-OH (red), BMPO-CR (black) and BMPO-CO2 (green) formed after dissolution of KO2 (final 40 mmol L−1) in 50 mmol L−1 phosphate buffer containing BMPO (20 mmol L−1) at (a) pH 11.5, (b) pH 9.0, (c) pH 8.0, (d) pH 7.8, (e) pH 7.7 and (f) continued measurement of (e), (g) pH 6.0 and (h) continued measurement of (g).
Figure 5. Comparison of pH-dependent absolute integral EPR intensity (total quantity of radicals in r.u.) of individual BMPO adducts elucidated from the simulation of the experimental EPR spectra. Spectral components: BMPO-OOH (blue), BMPO-OH (red), BMPO-CR (black) and BMPO-CO2 (green) formed after dissolution of KO2 (final 40 mmol L−1) in 50 mmol L−1 phosphate buffer containing BMPO (20 mmol L−1) at (a) pH 11.5, (b) pH 9.0, (c) pH 8.0, (d) pH 7.8, (e) pH 7.7 and (f) continued measurement of (e), (g) pH 6.0 and (h) continued measurement of (g).
Antioxidants 10 01286 g005
Figure 6. Effects of the compounds on the EPR spectra of BMPO adducts prepared through the addition of BMPO + HCl to powdered KO2. Final concentrations: BMPO + HCl/KO2 (20/40 in mmol L−1) in a 50 mmol L−1 phosphate buffer at pH 7.4. The arrangement of the spectra is the same as in Figure 1. (a1b3) Control EPR spectra and (c1d3) EPR spectra in the presence of 100 µmol L−1 Na2S, (e1f3) 100 µmol L−1 RSe-1, and (g1h3) 100 µmol L−1 RSe-2. For details of the sample preparation, see Procedure 3 in Supplementary Materials.
Figure 6. Effects of the compounds on the EPR spectra of BMPO adducts prepared through the addition of BMPO + HCl to powdered KO2. Final concentrations: BMPO + HCl/KO2 (20/40 in mmol L−1) in a 50 mmol L−1 phosphate buffer at pH 7.4. The arrangement of the spectra is the same as in Figure 1. (a1b3) Control EPR spectra and (c1d3) EPR spectra in the presence of 100 µmol L−1 Na2S, (e1f3) 100 µmol L−1 RSe-1, and (g1h3) 100 µmol L−1 RSe-2. For details of the sample preparation, see Procedure 3 in Supplementary Materials.
Antioxidants 10 01286 g006
Figure 7. Effects of the compounds on the EPR spectra of BMPO adducts prepared through the addition of BMPO + HCl to powdered KO2. Final concentrations: BMPO + HCl/KO2 (20/40 in mmol L−1) in 50 mmol L−1 phosphate buffer at pH 6.7. The arrangement of the spectra is the same as in Figure 1. (a1a3) Control EPR spectra and (b1b3) EPR spectra in the presence of 100 µmol L−1 Na2S, (c1c3) 100 µmol L−1 RSe-1, and (d1d3) 100 µmol L−1 RSe-2. For details of sample preparation, see Procedure 3 in Supplementary Materials.
Figure 7. Effects of the compounds on the EPR spectra of BMPO adducts prepared through the addition of BMPO + HCl to powdered KO2. Final concentrations: BMPO + HCl/KO2 (20/40 in mmol L−1) in 50 mmol L−1 phosphate buffer at pH 6.7. The arrangement of the spectra is the same as in Figure 1. (a1a3) Control EPR spectra and (b1b3) EPR spectra in the presence of 100 µmol L−1 Na2S, (c1c3) 100 µmol L−1 RSe-1, and (d1d3) 100 µmol L−1 RSe-2. For details of sample preparation, see Procedure 3 in Supplementary Materials.
Antioxidants 10 01286 g007
Figure 8. (a) Time dependencies of the total BMPO adduct radical concentration of the BMPO + HCl/KO2 (20/40 in mmol L−1) mixture (pH 7.4) with 100 µmol L−1 Na2S (blue), 100 µmol L−1 RSe-1 (green), and 100 µmol L−1 RSe-2 (red), as well as without any of these (black). Each point represents the average of five accumulated subsequent EPR spectra. Time starts after the addition of BMPO + HCl to powdered KO2. (b) The pH dependence of the integral EPR intensity of the total BMPO adducts (r.u.) of the first spectrum measured at 100 ± 15 s after the addition of BMPO + HCl to powdered KO2. Symbols have same meaning as in (a). Each point represents individual sample preparation.
Figure 8. (a) Time dependencies of the total BMPO adduct radical concentration of the BMPO + HCl/KO2 (20/40 in mmol L−1) mixture (pH 7.4) with 100 µmol L−1 Na2S (blue), 100 µmol L−1 RSe-1 (green), and 100 µmol L−1 RSe-2 (red), as well as without any of these (black). Each point represents the average of five accumulated subsequent EPR spectra. Time starts after the addition of BMPO + HCl to powdered KO2. (b) The pH dependence of the integral EPR intensity of the total BMPO adducts (r.u.) of the first spectrum measured at 100 ± 15 s after the addition of BMPO + HCl to powdered KO2. Symbols have same meaning as in (a). Each point represents individual sample preparation.
Antioxidants 10 01286 g008
Figure 9. Time dependence of the integral EPR intensity normalized to 100% of the individual BMPO-OOH and BMPO-OH adducts elucidated from the simulation of the experimental EPR spectra shown in Figure 6; Figure 7, at pH 7.4 (ad) and pH 6.7 (eh). Time started when BMPO + HCl was added to KO2. Spectral components: BMPO-OOH (blue) and BMPO-OH (red). (a,e) Control; (b,f) 100 µmol L−1 Na2S; (c,g) 100 µmol L−1 RSe-1; (d,h) 100 µmol L−1 RSe-2. Each point represents the average of five accumulated subsequent EPR spectra.
Figure 9. Time dependence of the integral EPR intensity normalized to 100% of the individual BMPO-OOH and BMPO-OH adducts elucidated from the simulation of the experimental EPR spectra shown in Figure 6; Figure 7, at pH 7.4 (ad) and pH 6.7 (eh). Time started when BMPO + HCl was added to KO2. Spectral components: BMPO-OOH (blue) and BMPO-OH (red). (a,e) Control; (b,f) 100 µmol L−1 Na2S; (c,g) 100 µmol L−1 RSe-1; (d,h) 100 µmol L−1 RSe-2. Each point represents the average of five accumulated subsequent EPR spectra.
Antioxidants 10 01286 g009
Figure 10. pH-dependent normalized integral EPR intensity of individual BMPO-OOH and BMPO-OH components elucidated from the simulation of the first experimental EPR spectrum recorded 100 ± 15 s after the addition of BMPO + HCl to powdered KO2. Spectral components: control BMPO-OOH (blue) and BMPO-OH (red) are from Figure 2b; 100 µmol L−1 Na2S (cyan and pink); 100 µmol L−1 RSe-1 (dark green and green), and 100 µmol L−1 RSe-2 (black and dark yellow). Each pair of complementary colors, BMPO-OOH and BMPO-OH, represents an individual sample preparation. The sum of the individual spectra of BMPO adducts was normalized to 100%.
Figure 10. pH-dependent normalized integral EPR intensity of individual BMPO-OOH and BMPO-OH components elucidated from the simulation of the first experimental EPR spectrum recorded 100 ± 15 s after the addition of BMPO + HCl to powdered KO2. Spectral components: control BMPO-OOH (blue) and BMPO-OH (red) are from Figure 2b; 100 µmol L−1 Na2S (cyan and pink); 100 µmol L−1 RSe-1 (dark green and green), and 100 µmol L−1 RSe-2 (black and dark yellow). Each pair of complementary colors, BMPO-OOH and BMPO-OH, represents an individual sample preparation. The sum of the individual spectra of BMPO adducts was normalized to 100%.
Antioxidants 10 01286 g010
Figure 11. pH-dependent EPR spectra of the BMPO adduct after the addition of BMPO to powdered KO2, followed by the adjustment of the final pH by HCl. The arrangement of the spectra is the same as in Figure 1. BMPO in the phosphate buffer was added to powdered KO2 and vortexed, and 30 s later, HCl was added to adjust the final solution pH. (a1a3) pH 10.3; (b1b3) pH 8.5; (c1c3) pH 7.3 and (d1d3) continued of (c1–c3); (e1e3) pH 6.5. Intensities of (a1e1) time-dependent EPR spectra and (a2e2,a3e3) detailed spectra are approximately comparable. Molar ratio of BMPO/KO2 was 20/40 (in mmol L−1), except for (a1a3), where the ratio was 56/56 (in mmol L−1). For details of the sample preparation, see Procedure 4 in Supplementary Materials.
Figure 11. pH-dependent EPR spectra of the BMPO adduct after the addition of BMPO to powdered KO2, followed by the adjustment of the final pH by HCl. The arrangement of the spectra is the same as in Figure 1. BMPO in the phosphate buffer was added to powdered KO2 and vortexed, and 30 s later, HCl was added to adjust the final solution pH. (a1a3) pH 10.3; (b1b3) pH 8.5; (c1c3) pH 7.3 and (d1d3) continued of (c1–c3); (e1e3) pH 6.5. Intensities of (a1e1) time-dependent EPR spectra and (a2e2,a3e3) detailed spectra are approximately comparable. Molar ratio of BMPO/KO2 was 20/40 (in mmol L−1), except for (a1a3), where the ratio was 56/56 (in mmol L−1). For details of the sample preparation, see Procedure 4 in Supplementary Materials.
Antioxidants 10 01286 g011
Figure 12. Representative normalized experimental EPR spectra of BMPO adducts along with their simulations. Arrangement of experimental and simulated spectra is the same as in Figure 3. EPR spectra at (a) pH 10.3, (b) pH 8.5, (c) pH 7.3, and (d) pH 6.5. Sample preparation: BMPO in the buffer was added to powdered KO2 and vortexed, and 30 s later HCl was added to adjust the final pH of the solution.
Figure 12. Representative normalized experimental EPR spectra of BMPO adducts along with their simulations. Arrangement of experimental and simulated spectra is the same as in Figure 3. EPR spectra at (a) pH 10.3, (b) pH 8.5, (c) pH 7.3, and (d) pH 6.5. Sample preparation: BMPO in the buffer was added to powdered KO2 and vortexed, and 30 s later HCl was added to adjust the final pH of the solution.
Antioxidants 10 01286 g012
Figure 13. (Left column) Comparison of time- and pH-dependent normalized integral EPR intensity of individual BMPO adducts elucidated from the simulation of the experimental EPR spectra. Spectral components: BMPO-OOH (blue), BMPO-OH (red), BMPO-CR (black), and BMPO-CO2 (green) at (a) pH 10.3, (b) pH 8.5, and (c) pH 7.3; (d) continued measurement of (c) for another 11 min; (e) pH 6.5. Each point represents the average of five accumulated subsequent EPR spectra. Time starts after the addition of BMPO to powdered KO2. The sum of the individual BMPO adducts of the accumulated spectra was normalized to 100%. (Right column) (fj) Comparison of time- and pH-dependent absolute integral EPR intensity (total quantity of radicals in r.u.) of individual BMPO adducts of normalized integral EPR intensity shown in the left column.
Figure 13. (Left column) Comparison of time- and pH-dependent normalized integral EPR intensity of individual BMPO adducts elucidated from the simulation of the experimental EPR spectra. Spectral components: BMPO-OOH (blue), BMPO-OH (red), BMPO-CR (black), and BMPO-CO2 (green) at (a) pH 10.3, (b) pH 8.5, and (c) pH 7.3; (d) continued measurement of (c) for another 11 min; (e) pH 6.5. Each point represents the average of five accumulated subsequent EPR spectra. Time starts after the addition of BMPO to powdered KO2. The sum of the individual BMPO adducts of the accumulated spectra was normalized to 100%. (Right column) (fj) Comparison of time- and pH-dependent absolute integral EPR intensity (total quantity of radicals in r.u.) of individual BMPO adducts of normalized integral EPR intensity shown in the left column.
Antioxidants 10 01286 g013
Figure 14. Potency of compounds to induce pDNA cleavage at pH 6.5 (green), 7.4 (red), 8.0 (cyan), and 8.5 pH (pink) in a 25 mmol L−1 sodium phosphate buffer and 50 µmol L−1 DTPA at 37 °C. Control without and with 150 µmol L−1 FeCl2; controls with 5 mmol L−1 BMPO, 5 mmol L−1 H2O2, 10 mmol L−1 KO2, and 5 mmol L−1 H2O2 + 10 mmol L−1 KO2. Sample (BMPO + HCL) + KO2: BMPO (final 5 mmol L−1) in a phosphate buffer adjusted by HCl (to get required pH of BMPO/KO2 mixture) was added to powdered KO2 (final 10 mmol L−1), then the mixture was added to the pDNA solution (see Procedure 6 in Supplementary Materials). Sample (BMPO + HCL) + KO2 adjusted to pH 7.4: solutions were prepared as for previous samples with various pH levels, but HCl or NaOH were added to the pDNA solution to standardize the pH to 7.4 (see Procedure 7 in Supplementary Materials). Sample (Buffer + HCl) + KO2 + BMPO: phosphate buffer adjusted by HCl was added to powder KO2 (final 10 mmol L−1), followed by the addition of BMPO (final 5 mmol L−1) 10 s later, and the mixture was applied to the pDNA solution (see Procedure 8 in Supplementary Materials). The final concentration of pDNA was 0.2 µg in 20 µL. IR of nc DNA form represents the relative intensity of the nicked circular pDNA. Data represent values from individual samples. Horizontal black marks indicate means ± SD.
Figure 14. Potency of compounds to induce pDNA cleavage at pH 6.5 (green), 7.4 (red), 8.0 (cyan), and 8.5 pH (pink) in a 25 mmol L−1 sodium phosphate buffer and 50 µmol L−1 DTPA at 37 °C. Control without and with 150 µmol L−1 FeCl2; controls with 5 mmol L−1 BMPO, 5 mmol L−1 H2O2, 10 mmol L−1 KO2, and 5 mmol L−1 H2O2 + 10 mmol L−1 KO2. Sample (BMPO + HCL) + KO2: BMPO (final 5 mmol L−1) in a phosphate buffer adjusted by HCl (to get required pH of BMPO/KO2 mixture) was added to powdered KO2 (final 10 mmol L−1), then the mixture was added to the pDNA solution (see Procedure 6 in Supplementary Materials). Sample (BMPO + HCL) + KO2 adjusted to pH 7.4: solutions were prepared as for previous samples with various pH levels, but HCl or NaOH were added to the pDNA solution to standardize the pH to 7.4 (see Procedure 7 in Supplementary Materials). Sample (Buffer + HCl) + KO2 + BMPO: phosphate buffer adjusted by HCl was added to powder KO2 (final 10 mmol L−1), followed by the addition of BMPO (final 5 mmol L−1) 10 s later, and the mixture was applied to the pDNA solution (see Procedure 8 in Supplementary Materials). The final concentration of pDNA was 0.2 µg in 20 µL. IR of nc DNA form represents the relative intensity of the nicked circular pDNA. Data represent values from individual samples. Horizontal black marks indicate means ± SD.
Antioxidants 10 01286 g014
Table 1. The hfcc of BMPO spin adducts elucidated from simulations of experimental spectra measured in phosphate buffer solutions containing KO2. BMPO-OOH and BMPO-OH were simulated considering the presence of two conformers.
Table 1. The hfcc of BMPO spin adducts elucidated from simulations of experimental spectra measured in phosphate buffer solutions containing KO2. BMPO-OOH and BMPO-OH were simulated considering the presence of two conformers.
BMPO-AdductaN, mTaHβ, mTaHγ, mT
BMPO-OH(1)1.433 ± 0.0031.521 ± 0.0050.074 ± 0.004
BMPO-OH(2)1.421 ± 0.0041.264 ± 0.0030.065 ± 0.002
BMPO-OOH(1)1.341 ± 0.0031.198 ± 0.004
BMPO-OOH(2)1.340 ± 0.0010.967 ± 0.006
BMPO-CR1.515 ± 0.0082.077 ± 0.024
BMPO-CO21.490 ± 0.0031.710 ± 0.012
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Misak, A.; Brezova, V.; Chovanec, M.; Luspai, K.; Nasim, M.J.; Grman, M.; Tomasova, L.; Jacob, C.; Ondrias, K. EPR Study of KO2 as a Source of Superoxide and BMPO-OH/OOH Radical That Cleaves Plasmid DNA and Detects Radical Interaction with H2S and Se-Derivatives. Antioxidants 2021, 10, 1286. https://doi.org/10.3390/antiox10081286

AMA Style

Misak A, Brezova V, Chovanec M, Luspai K, Nasim MJ, Grman M, Tomasova L, Jacob C, Ondrias K. EPR Study of KO2 as a Source of Superoxide and BMPO-OH/OOH Radical That Cleaves Plasmid DNA and Detects Radical Interaction with H2S and Se-Derivatives. Antioxidants. 2021; 10(8):1286. https://doi.org/10.3390/antiox10081286

Chicago/Turabian Style

Misak, Anton, Vlasta Brezova, Miroslav Chovanec, Karol Luspai, Muhammad Jawad Nasim, Marian Grman, Lenka Tomasova, Claus Jacob, and Karol Ondrias. 2021. "EPR Study of KO2 as a Source of Superoxide and BMPO-OH/OOH Radical That Cleaves Plasmid DNA and Detects Radical Interaction with H2S and Se-Derivatives" Antioxidants 10, no. 8: 1286. https://doi.org/10.3390/antiox10081286

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop